Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancerSCIENCE TRANSLATIONAL MEDICINEIF14.62023-01-118OA
CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung CancerJOURNAL OF NUCLEAR MEDICINEIF9.12022-04-288OA